Transplant Recipients Skin Cancer Care More Costly Than Nonimmunosuppressed Patients

Long-Term Disease Control from Definitive Radiation Therapy for Inoperable Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma After Treatment with New Graft-Versus-Host-Disease Medications

Lower Number of CD3+ T-Lymphocytes Associated with Higher Risk of cSCC Metastasis

Prevalence of Total Body Skin Exams Increased from 2005-2015

The Highest Yield Period for Detecting cSCC Recurrence is the First 3 Years After Diagnosis

40-GEP Assists in Determining Prognosis of Head and Neck Cutaneous Squamous Cell Carcinoma

Increase in Compliance of TBSE Following Dermatologic Surgery via Reminder Phone Calls

No Association Found Between Sentinel Lymph Node Biopsy Timing and Success

Most Squamous Cell Carcinoma Recurrences Occur Within 3 Years of Diagnosis

Preoperative tumor location does not reliably predict canalicular injury after Mohs surgery

Effectiveness of neoadjuvent Cemiplimab for cSCC. Who gets it?

Lymphovascular invasion associated with higher death & metastasis rates in cutaneous SCC

Oral nicotinamide may have a chemoprophylactic role against actinic keratoses and NMSC

In-transit metastasis may be overlooked as an important risk factor in cSCC staging

Minimal impact from 1-year dermoscopy training for primary care providers

Delays in Mohs surgery may adversely affect outcomes for poorly-differentiated SCCs

Superficial Radiation Therapy may be beneficial option for early stage NMSCs